InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $173.620 1.2 (0.70%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,138 Dividend/Distribution - PME 20 Aug 2020 9:18AM $25.310 $173.620 risen by 585.97%
$18,138 Appendix 4G and Corporate Governance Statement 20 Aug 2020 9:15AM $25.310 $173.620 risen by 585.97%
$18,138 PME Full year results 20 Aug 2020 9:14AM $25.310 $173.620 risen by 585.97%
$18,138 Full Year Statutory Accounts 20 Aug 2020 9:13AM $25.310 $173.620 risen by 585.97%
$18,138 Preliminary Final Report 20 Aug 2020 9:12AM $25.310 $173.620 risen by 585.97%
$18,138 PME Results release date 5 Aug 2020 9:03AM $23.730 $173.620 risen by 631.65%
$18,138 Initial Director's Interest Notice 3 Aug 2020 8:33AM $23.920 $173.620 risen by 625.84%
$18,138 PME appoints new Non-Executive Director 27 Jul 2020 9:07AM $23.800 $173.620 risen by 629.50%
$18,138 Interview with CEO - Northwestern announcement 1 Jun 2020 9:32AM $28.830 $173.620 risen by 502.22%
$18,138 PME signs A$22M deal with Northwestern Memorial Healthcare 1 Jun 2020 9:29AM $28.830 $173.620 risen by 502.22%
$18,138 On market share buy-back 30 Mar 2020 9:00AM $18.290 $173.620 risen by 849.26%
$18,138 Change of Director's Interest Notice - Anthony Glenning 23 Mar 2020 9:20AM $17.240 $173.620 risen by 907.08%
$18,138 Change of Director's Interest Notice - Leigh Farrell 18 Mar 2020 9:21AM $15.890 $173.620 risen by 992.64%
$18,138 Change of Director's Interest Notice - Sam Hupert 18 Mar 2020 9:20AM $15.890 $173.620 risen by 992.64%
$18,138 Change of Director's Interest Notice - Anthony Hall 18 Mar 2020 9:18AM $15.890 $173.620 risen by 992.64%
$18,138 HY2020 Results Presentation 13 Feb 2020 10:56AM $28.710 $173.620 risen by 504.74%
$18,138 Open Briefing - CEO on HY20 results 13 Feb 2020 10:02AM $27.300 $173.620 risen by 535.97%
$18,138 Dividend/Distribution - PME 13 Feb 2020 9:33AM $27.300 $173.620 risen by 535.97%
$18,138 Company Announcement - Interim Results 13 Feb 2020 9:25AM $27.300 $173.620 risen by 535.97%
$18,138 Half Year Accounts 13 Feb 2020 9:24AM $27.300 $173.620 risen by 535.97%
$18,138 Appendix 4D 13 Feb 2020 9:23AM $27.300 $173.620 risen by 535.97%
$18,138 PME Results release date 5 Feb 2020 1:54PM $25.250 $173.620 risen by 587.60%
$18,138 PME signs 5 year cloud based platform deal with Nines 30 Dec 2019 9:29AM $23.520 $173.620 risen by 638.18%
$18,138 RSNA update 16 Dec 2019 9:53AM $21.730 $173.620 risen by 698.99%
$18,138 PME - Showcase AI Accelerator at RSNA 28 Nov 2019 9:56AM $25.520 $173.620 risen by 580.33%

376 - 400 of 679 results

Page 16 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.